We are live on ! Find out more
TVRD

Tvardi Therapeutics
TVRD

114 hedge funds and large institutions have $296M invested in Tvardi Therapeutics in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 36 increasing their positions, 29 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

182% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 11

130% more capital invested

Capital invested by funds: $129M → $296M (+$167M)

24% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 29

13% more funds holding

Funds holding: 101 → 114 (+13)

0.31% more ownership

Funds ownership: 1.41% → 1.72% (+0.31%)

25% less call options, than puts

Call options by funds: $11.2M | Put options by funds: $15.1M

Holders
114
Holders Change
+13
Holders Change %
+12.87%
% of All Funds
2.84%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
31
Increased
36
Reduced
29
Closed
11
Calls
$11.2M
Puts
$15.1M
Net Calls
-$3.83M
Net Calls Change
-$5.03M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$20.9M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$13.3M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$12.6M
4
RCP
Rho Capital Partners
New York
+$7.42M
5
Jennison Associates
Jennison Associates
New York
+$4.45M

Top Sellers

Rank Fund Capital Flow
1
Allianz Asset Management
Allianz Asset Management
Germany
-$2.07M
2
NC
Nexthera Capital
New York
-$1.93M
3
DCM
DAFNA Capital Management
California
-$1.69M
4
CWG
C WorldWide Group
Denmark
-$1.56M
5
OM
Opaleye Management
Massachusetts
-$1.34M
Name Holding Trade Value Shares
Change 		Change in
Stake
TAM
26
Tiverton Asset Management
Delaware
$2.59M – – –
Allianz Asset Management
27
Allianz Asset Management
Germany
$2.22M -$2.07M -3,884 -54%
NC
28
Nexthera Capital
New York
$2.21M -$1.93M -3,611 -52%
Stifel Financial
29
Stifel Financial
Missouri
$2.12M +$1.71M +3,207 New
Voloridge Investment Management
30
Voloridge Investment Management
Florida
$1.89M +$1.53M +2,857 New
PPA
31
Parametric Portfolio Associates
Washington
$1.82M +$612K +1,146 +71%
DCM
32
DAFNA Capital Management
California
$1.75M -$1.69M -3,172 -55%
Ameriprise
33
Ameriprise
Minnesota
$1.49M -$346K -648 -22%
Barclays
34
Barclays
United Kingdom
$1.37M +$112K +210 +11%
MSU
35
Mizuho Securities USA
New York
$1.35M +$1.15M +2,153 New
Tudor Investment Corp
36
Tudor Investment Corp
Connecticut
$1.35M +$1.09M +2,045 New
Federated Hermes
37
Federated Hermes
Pennsylvania
$1.1M +$891K +1,667 New
SKK
38
Shepherd Kaplan Krochuk
Massachusetts
$974K -$511K -957 -39%
Citadel Advisors
39
Citadel Advisors
Florida
$924K +$573K +1,072 +331%
Russell Investments Group
40
Russell Investments Group
United Kingdom
$918K +$101K +190 +16%
NPC
41
National Planning Corporation
California
$867K -$213K -399 -22%
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$761K -$28.3K -53 -4%
DCM
43
Driehaus Capital Management
Illinois
$750K +$605K +1,133 New
Charles Schwab
44
Charles Schwab
California
$729K +$178K +333 +43%
TA
45
Teachers Advisors
New York
$725K +$89.2K +167 +18%
Bank of Montreal
46
Bank of Montreal
Ontario, Canada
$708K +$134K +250 +30%
VKH
47
Virtu KCG Holdings
New York
$673K +$543K +1,017 New
Jane Street
48
Jane Street
New York
$645K +$521K +975 New
VEA
49
Virtus ETF Advisers
New York
$596K +$45.9K +86 +11%
EP
50
Elkfork Partners
Oregon
$586K – – –
1
2
3 4 5

TVRD Hedge Fund Activity: Q1 2017 in Review

114 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Tvardi Therapeutics (TVRD) for Q1 2017, worth a combined $296M — up 130% from $129M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new TVRD positions and 11 closed out — a net gain of 20 holders — while 36 added to existing stakes and 29 trimmed.

The largest buyer was BlackRock, adding an estimated $20.9M. The largest seller was Allianz Asset Management, cutting an estimated $2.07M.

  • 114 institutional investors held Tvardi Therapeutics (TVRD) as of Q1 2017, up from 101 in Q4 2016.
  • Funds reported $296M of Tvardi Therapeutics stock for Q1 2017, up 130% quarter-over-quarter.
  • 31 funds opened new Tvardi Therapeutics positions in Q1 2017 and 11 closed out, a net change of +20 holders.
  • The largest Tvardi Therapeutics buyer in Q1 2017 was BlackRock, an estimated $20.9M added.
  • The largest Tvardi Therapeutics seller in Q1 2017 was Allianz Asset Management, an estimated $2.07M sold.

Based on aggregated 13F filings for Q1 2017.